OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Suvorexant: scientifically interesting, utility uncertain
Nicholas A Keks, Judy Hope, Simone Keogh
Australasian Psychiatry (2017) Vol. 25, Iss. 6, pp. 622-624
Closed Access | Times Cited: 17
Nicholas A Keks, Judy Hope, Simone Keogh
Australasian Psychiatry (2017) Vol. 25, Iss. 6, pp. 622-624
Closed Access | Times Cited: 17
Showing 17 citing articles:
Effects of daridorexant on rest/wake activity patterns and drinking in adult rats exposed to chronic ethanol vapor in adolescence
Leslie R. Amodeo, Derek N. Wills, Jason Benedict, et al.
Alcohol (2025)
Open Access
Leslie R. Amodeo, Derek N. Wills, Jason Benedict, et al.
Alcohol (2025)
Open Access
The Orexin System and Its Impact on the Autonomic Nervous and Cardiometabolic System in Post-Acute Sequelae of COVID-19
Jana Ruhrländer, Styliani Syntila, Elisabeth Schieffer, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 545-545
Open Access
Jana Ruhrländer, Styliani Syntila, Elisabeth Schieffer, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 545-545
Open Access
Effect of gabapentin on sleep and delta and theta EEG power in adult rats exposed to chronic intermittent ethanol vapor and protracted withdrawal during adolescence
Cindy L. Ehlers, Manuel Sánchez-Alavez, Derek N. Wills
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1783-1791
Open Access | Times Cited: 26
Cindy L. Ehlers, Manuel Sánchez-Alavez, Derek N. Wills
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1783-1791
Open Access | Times Cited: 26
Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs
Fernanda Majolo, Lavynia Ferreira Hoffmann, Wilian Luan Pilatti Sant’Ana, et al.
Frontiers in clinical drug research. CNS and neurological disorders (2024), pp. 1-58
Open Access | Times Cited: 1
Fernanda Majolo, Lavynia Ferreira Hoffmann, Wilian Luan Pilatti Sant’Ana, et al.
Frontiers in clinical drug research. CNS and neurological disorders (2024), pp. 1-58
Open Access | Times Cited: 1
PSPH-D-18-00526: Effect of a dual orexin receptor antagonist (DORA-12) on sleep and event-related oscillations in rats exposed to ethanol vapor during adolescence
Cindy L. Ehlers, Jessica Benedict, Derek N. Wills, et al.
Psychopharmacology (2019) Vol. 237, Iss. 10, pp. 2917-2927
Open Access | Times Cited: 10
Cindy L. Ehlers, Jessica Benedict, Derek N. Wills, et al.
Psychopharmacology (2019) Vol. 237, Iss. 10, pp. 2917-2927
Open Access | Times Cited: 10
Medikamente zur Behandlung von Schlafstörungen
Axel Steiger, Frank Weber, Otto Benkert
Springer eBooks (2018), pp. 555-640
Closed Access | Times Cited: 8
Axel Steiger, Frank Weber, Otto Benkert
Springer eBooks (2018), pp. 555-640
Closed Access | Times Cited: 8
Updates and confounding factors in delayed sleep–wake phase disorder
Alexandra Wu
Sleep and Biological Rhythms (2023) Vol. 21, Iss. 3, pp. 279-287
Open Access | Times Cited: 2
Alexandra Wu
Sleep and Biological Rhythms (2023) Vol. 21, Iss. 3, pp. 279-287
Open Access | Times Cited: 2
Drug-induced psychiatric disorders: A pharmacovigilance update
François Montastruc, Tanguy Taillefer de Laportalière
Therapies (2023) Vol. 79, Iss. 2, pp. 173-179
Closed Access | Times Cited: 2
François Montastruc, Tanguy Taillefer de Laportalière
Therapies (2023) Vol. 79, Iss. 2, pp. 173-179
Closed Access | Times Cited: 2
Medikamente zur Behandlung von Schlafstörungen
Axel Steiger, Frank Weber, Otto Benkert
Springer eBooks (2023), pp. 539-635
Closed Access | Times Cited: 2
Axel Steiger, Frank Weber, Otto Benkert
Springer eBooks (2023), pp. 539-635
Closed Access | Times Cited: 2
Lemborexant, an orexin receptor antagonist sedative-hypnotic: Is it useful for insomnia in psychiatric disorders?
Nicholas A Keks, Judy Hope
Australasian Psychiatry (2022) Vol. 30, Iss. 4, pp. 530-532
Closed Access | Times Cited: 4
Nicholas A Keks, Judy Hope
Australasian Psychiatry (2022) Vol. 30, Iss. 4, pp. 530-532
Closed Access | Times Cited: 4
CYP450-Mediated metabolism of suvorexant and investigation of metabolites in forensic case specimens
Britni Skillman, Sarah Kerrigan
Forensic Science International (2020) Vol. 312, pp. 110307-110307
Closed Access | Times Cited: 5
Britni Skillman, Sarah Kerrigan
Forensic Science International (2020) Vol. 312, pp. 110307-110307
Closed Access | Times Cited: 5
Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC
Nagaraju Rajana, Dharamasoth Rama Devi, Dinne Naresh Kumar Reddy, et al.
Journal of Chromatographic Science (2020) Vol. 58, Iss. 5, pp. 433-444
Closed Access | Times Cited: 4
Nagaraju Rajana, Dharamasoth Rama Devi, Dinne Naresh Kumar Reddy, et al.
Journal of Chromatographic Science (2020) Vol. 58, Iss. 5, pp. 433-444
Closed Access | Times Cited: 4
Short-Term Efficacy and Safety of Suvorexant and Lemborexant: A Retrospective Study
Koki Mori, M Kimura, Eiseki Usami
Cureus (2024)
Open Access
Koki Mori, M Kimura, Eiseki Usami
Cureus (2024)
Open Access
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).
Amnon A. Berger, Emily Sottosanti, Ariel Winnick, et al.
PubMed (2022) Vol. 52, Iss. 1, pp. 68-90
Closed Access | Times Cited: 2
Amnon A. Berger, Emily Sottosanti, Ariel Winnick, et al.
PubMed (2022) Vol. 52, Iss. 1, pp. 68-90
Closed Access | Times Cited: 2
Toxicology of Specific Substances
Alan Wayne Jones, Frank Mußhoff, T. Krämer, et al.
(2022), pp. 1167-1312
Closed Access | Times Cited: 2
Alan Wayne Jones, Frank Mußhoff, T. Krämer, et al.
(2022), pp. 1167-1312
Closed Access | Times Cited: 2
Treating Insomnia in Older Adult Patients: Limiting Benzodiazepine Use
Joseph V. Pergolizzi, Robert Joseph Taylor, Jo Ann LeQuang, et al.
Pharmacology & Pharmacy (2019) Vol. 10, Iss. 03, pp. 116-129
Open Access | Times Cited: 2
Joseph V. Pergolizzi, Robert Joseph Taylor, Jo Ann LeQuang, et al.
Pharmacology & Pharmacy (2019) Vol. 10, Iss. 03, pp. 116-129
Open Access | Times Cited: 2
Medikamente zur Behandlung von Schlafstörungen
Axel Steiger, Frank Weber, Otto Benkert
Springer eBooks (2020), pp. 499-579
Closed Access | Times Cited: 1
Axel Steiger, Frank Weber, Otto Benkert
Springer eBooks (2020), pp. 499-579
Closed Access | Times Cited: 1
